Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

Jayant Mishra said he was approved for a copay card covering $9,450 a year. He didn't realize how fast the money would run out.

Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment for plaque psoriasis.

The UK's NHS sets prices it pays for medicines through a mix of cost-control agreements and other assessments. In England, ...

Amgen Inc. and GSK plc are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer substantial discounts on prescription drugs. This move will augment the ...

Launched in January, TrumpRx.gov is part of a series of most-favored-nation deals struck between the Trump administration and ...

Johnson & Johnson JNJ rapidly advanced its pipeline in 2025, attaining significant clinical and regulatory milestones that will help drive growth through the back half of the decade. In 2025, it ...

By Bhanvi Satija and Michael Erman March 18 (Reuters) - U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is ...

Latest update reveals that U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across ...

State pensioners with certain health conditions or disabilities are being handed a payment boost of up to £218 per year with ...

Diamond Hill Capital, an investment management company, released its “Mid Strategy” fourth-quarter 2025 investor letter. A ...

New guidelines recommend considering cholesterol-lowering statins in the 30s, screening all adults for hidden risk factors ...